Euclid Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-99,535
Closed -$8.64M 293
2016
Q2
$8.64M Buy
99,535
+12,690
+15% +$1.03M 0.38% 97
2016
Q1
$6.51M Sell
86,845
-42,605
-33% -$3.21M 0.25% 145
2015
Q4
$9.96M Buy
+129,450
New +$9.74M 0.3% 113
2015
Q3
Sell
-63,730
Closed -$4.72M 358
2015
Q2
$4.72M Sell
63,730
-457,860
-88% -$35M 0.09% 243
2015
Q1
$40.7M Buy
+521,590
New +$39.5M 0.75% 25
2014
Q4
Sell
-500,900
Closed -$31M 450
2014
Q3
$31M Buy
500,900
+21,220
+4% +$1.35M 0.22% 106
2014
Q2
$30.6M Sell
479,680
-75,304
-14% -$4.57M 0.21% 113
2014
Q1
$34.2M Buy
554,984
+153,420
+38% +$8.94M 0.26% 85
2013
Q4
$23M Sell
401,564
-20,630
-5% -$1.17M 0.19% 118
2013
Q3
$22.5M Buy
422,194
+82,889
+24% +$4.46M 0.23% 101
2013
Q2
$17.5M Buy
+339,305
New +$16.8M 0.22% 115

Other funds holding MDT

Euclid Advisors's MDT Position: Q3 2016 in Review

Euclid Advisors sold out of Medtronic (MDT) in Q3 2016, closing a stake of 99,535 shares — an estimated $8.64M sold.

Euclid Advisors first reported a position in MDT in Q2 2013 and held it in 11 quarters. The position peaked at $40.7M in Q1 2015. 1,267 funds tracked by Wall St. Rank hold MDT as of Q3 2016.

  • Euclid Advisors reported no remaining Medtronic position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 99,535 Medtronic shares in Q3 2016, an estimated $8.64M.
  • Euclid Advisors first reported a position in Medtronic in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Medtronic position peaked at $40.7M in Q1 2015.
  • 1,267 funds tracked by Wall St. Rank held Medtronic as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.